Skip to content

Clinical trials

Endocrine System Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Country / region: United States Clear all

143 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20052
20061
20072
20084
20094
20104
20117
20125
20134
20143
20155
20168
20179
20189
20197
20207
20219
20226
20236
20248
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed83
Recruiting20
Terminated14
Active, not recruiting9
Unknown status9
Withdrawn5
Suspended2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)13
Eli Lilly and Company9
University of Pittsburgh8
AstraZeneca6
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)6
Ascendis Pharma Endocrinology Division A/S4
M.D. Anderson Cancer Center4
Ascendis Pharma A/S3
Goldfinch Bio, Inc.3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases143
Diabetes Mellitus49
Glucose Metabolism Disorders45
Metabolic Diseases44
Diabetes Mellitus, Type 234
Rare Diseases17
Obesity12
Autoimmune Diseases11
Hypogonadism11
Neoplasms11

Trials

Showing 26 to 50 of 143. Each trial links to its page on Pharma Observatory.

43 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.